373 related articles for article (PubMed ID: 22614326)
21. An Arabic Version of the Cognitive Subscale of the Alzheimer's Disease Assessment Scale (ADAS-Cog): Reliability, Validity, and Normative Data.
Ben Jemaa S; Attia Romdhane N; Bahri-Mrabet A; Jendli A; Le Gall D; Bellaj T
J Alzheimers Dis; 2017; 60(1):11-21. PubMed ID: 28505978
[TBL] [Abstract][Full Text] [Related]
22. Comparison of the utility of everyday memory test and the Alzheimer's Disease Assessment Scale-Cognitive part for evaluation of mild cognitive impairment and very mild Alzheimer's disease.
Adachi H; Shinagawa S; Komori K; Toyota Y; Mori T; Matsumoto T; Sonobe N; Kashibayashi T; Ishikawa T; Fukuhara R; Ikeda M
Psychiatry Clin Neurosci; 2013 Apr; 67(3):148-53. PubMed ID: 23581865
[TBL] [Abstract][Full Text] [Related]
23. [Diagnostic value and functional correlations of the ADAS-Cog scale in Alzheimer's disease: data on NORMACODEM project].
Monllau A; Pena-Casanova J; Blesa R; Aguilar M; Bohm P; Sol JM; Hernandez G
Neurologia; 2007 Oct; 22(8):493-501. PubMed ID: 17602338
[TBL] [Abstract][Full Text] [Related]
24. Reliability and concurrent validity of Alzheimer's disease assessment scale - Cognitive subscale, Chinese version (ADAS-Cog-C) among Chinese community-dwelling older people population.
Jiang Y; Yang H; Zhao J; Wu Y; Zhou X; Cheng Z
Clin Neuropsychol; 2020 Dec; 34(sup1):43-53. PubMed ID: 32279575
[TBL] [Abstract][Full Text] [Related]
25. The Alzheimer's Disease Assessment Scale-Cognitive Subscale (ADAS-Cog): Modifications and Responsiveness in Pre-Dementia Populations. A Narrative Review.
Kueper JK; Speechley M; Montero-Odasso M
J Alzheimers Dis; 2018; 63(2):423-444. PubMed ID: 29660938
[TBL] [Abstract][Full Text] [Related]
26. Is the Alzheimer's Disease Assessment Scale-Cognitive Subscale Useful in Screening for Mild Cognitive Impairment and Alzheimer's Disease? A Systematic Review.
Park SH; Han KS
Curr Alzheimer Res; 2022; 19(3):202-211. PubMed ID: 35379127
[TBL] [Abstract][Full Text] [Related]
27. The use of the Hungarian Test Your Memory (TYM-HUN), MMSE, and ADAS-Cog tests for patients with mild cognitive impairment (MCI) in a Hungarian population: a cross-sectional study.
Garbóczy S; Magócs É; Szőllősi GJ; Harsányi S; Égerházi A; Kolozsvári LR
BMC Psychiatry; 2020 Dec; 20(1):571. PubMed ID: 33256672
[TBL] [Abstract][Full Text] [Related]
28. The validity and reliability of the Turkish version of Alzheimer's Disease Assessment Scale-Cognitive Subscale (ADAS-Cog) in patients with mild and moderate Alzheimer's disease and normal subjects.
Mavioglu H; Gedizlioglu M; Akyel S; Aslaner T; Eser E
Int J Geriatr Psychiatry; 2006 Mar; 21(3):259-65. PubMed ID: 16477580
[TBL] [Abstract][Full Text] [Related]
29. Normative Data of Mini-Mental State Examination, Montreal Cognitive Assessment, and Alzheimer's Disease Assessment Scale-Cognitive Subscale of Community-Dwelling Older Adults in Taiwan.
Wei YC; Chen CK; Lin C; Chen PY; Hsu PC; Lin CP; Shyu YC; Huang WY
Dement Geriatr Cogn Disord; 2022; 51(4):365-376. PubMed ID: 35820405
[TBL] [Abstract][Full Text] [Related]
30. Predictors of placebo group decline in the Alzheimer's disease Assessment Scale-cognitive subscale (ADAS-Cog) in 24 week clinical trials of Alzheimer's disease.
Irizarry MC; Webb DJ; Bains C; Barrett SJ; Lai RY; Laroche JP; Hosford D; Maher-Edwards G; Weil JG
J Alzheimers Dis; 2008 Jul; 14(3):301-11. PubMed ID: 18599956
[TBL] [Abstract][Full Text] [Related]
31. Discriminant Potential of the Alzheimer's Disease Assessment Scale-Cognitive Subscale (ADAS-Cog) in Greek Older Adults with Subjective Cognitive Decline and Mild Cognitive Impairment.
Tsatali M; Moraitou D; Gialaouzidis M; Bakoglidou E; Psaltis V; Bertzes N; Hassanin HI; Emmanouilidou E; Totonidis M; Frantzi N; Avdikou K; Gavra A; Diamantidou A; Kapsali N; Kouroundi E; Tsolaki M
J Alzheimers Dis Rep; 2024; 8(1):543-554. PubMed ID: 38549629
[TBL] [Abstract][Full Text] [Related]
32. Associations between cognitive, functional, and FDG-PET measures of decline in AD and MCI.
Landau SM; Harvey D; Madison CM; Koeppe RA; Reiman EM; Foster NL; Weiner MW; Jagust WJ;
Neurobiol Aging; 2011 Jul; 32(7):1207-18. PubMed ID: 19660834
[TBL] [Abstract][Full Text] [Related]
33. Cortical signatures of cognition and their relationship to Alzheimer's disease.
Gross AL; Manly JJ; Pa J; Johnson JK; Park LQ; Mitchell MB; Melrose RJ; Inouye SK; McLaren DG;
Brain Imaging Behav; 2012 Dec; 6(4):584-98. PubMed ID: 22718430
[TBL] [Abstract][Full Text] [Related]
34. Comparison of CSF markers and semi-quantitative amyloid PET in Alzheimer's disease diagnosis and in cognitive impairment prognosis using the ADNI-2 database.
Ben Bouallègue F; Mariano-Goulart D; Payoux P;
Alzheimers Res Ther; 2017 Apr; 9(1):32. PubMed ID: 28441967
[TBL] [Abstract][Full Text] [Related]
35. Sensitivity of memory subtests and learning slopes from the ADAS-Cog to distinguish along the continuum of the NIA-AA Research Framework for Alzheimer's Disease.
Hammers DB; Kostadinova RV; Spencer RJ; Ikanga JN; Unverzagt FW; Risacher SL; Apostolova LG;
Neuropsychol Dev Cogn B Aging Neuropsychol Cogn; 2023; 30(6):866-884. PubMed ID: 36074015
[TBL] [Abstract][Full Text] [Related]
36. The reliability and validity of the Alzheimer's Disease Assessment Scale Cognitive Subscale (ADAS-Cog) among the elderly Chinese in Hong Kong.
Chu LW; Chiu KC; Hui SL; Yu GK; Tsui WJ; Lee PW
Ann Acad Med Singap; 2000 Jul; 29(4):474-85. PubMed ID: 11056778
[TBL] [Abstract][Full Text] [Related]
37. [Is it pseudo-dementia? The validation of the Adas-Cog questionnaire in Hungary].
Drótos G; Pákáski M; Papp E; Kálmán J
Psychiatr Hung; 2012; 27(2):82-91. PubMed ID: 22700619
[TBL] [Abstract][Full Text] [Related]
38. State, trait, and accumulated features of the Alzheimer's Disease Assessment Scale Cognitive Subscale (ADAS-Cog) in mild Alzheimer's disease.
Cogo-Moreira H; Krance SH; Wu CY; Lanctôt KL; Herrmann N; Black SE; MacIntosh BJ; Rabin JS; Eid M; Swardfager W;
Alzheimers Dement (N Y); 2023; 9(1):e12376. PubMed ID: 36994227
[TBL] [Abstract][Full Text] [Related]
39. Cognition and motor function: The gait and cognition pooled index.
Kueper JK; Lizotte DJ; Montero-Odasso M; Speechley M;
PLoS One; 2020; 15(9):e0238690. PubMed ID: 32915845
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
